Levy, B. P. Et Al. 2018. Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15 .

Levy, B. P., Paz-Ares, L. G., Bennouna, J., Felip, E., Abreu, D. R., Isla, D., ... Barlesi, F.(2018). Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.

Levy, Benjamin Et Al. "Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018

Levy, Benjamin P. Et Al. "Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018

Levy, B. P. Et Al. (2018) . "Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.

@article{article, author={Benjamin Philip Levy Et Al. }, title={Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2018}